Bio-Techne Corporation (BVMF:T1CH34)
Brazil flag Brazil · Delayed Price · Currency is BRL
11.99
-0.40 (-3.23%)
At close: Jan 23, 2026

Revenue by Geography

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
United States Revenue
660.11M683.23M657.75M
United States Revenue Growth
-3.38%3.87%2.38%
EMEA ex-UK Revenue
277.33M266.31M241.43M
EMEA ex-UK Revenue Growth
4.14%10.30%9.63%
United Kingdom Revenue
54.57M54.83M50.01M
United Kingdom Revenue Growth
-0.46%9.63%1.12%
APAC ex-Greater China Revenue
82.02M77.26M73.90M
APAC ex-Greater China Revenue Growth
6.16%4.54%0.98%
Greater China Revenue
102.53M100.46M99.47M
Greater China Revenue Growth
2.05%1.00%-12.65%
Rest of World Revenue
39.02M37.55M36.50M
Rest of World Revenue Growth
3.93%2.87%-2.65%
Revenue (Other)
-1.00K--
Revenue (Total)
1.22B1.22B1.16B
Revenue (Total) Growth
-0.33%5.23%1.97%

Revenue

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
Protein Sciences Revenue
871.43M870.25M830.90M
Protein Sciences Revenue Growth
0.14%4.74%-1.75%
Diagnostics and Genomics Revenue
339.57M346.26M326.39M
Diagnostics and Genomics Revenue Growth
-1.93%6.09%11.55%
Other Segment Revenue
-4.15M4.15M
Other Segment Revenue Growth
--0.02%-
Intersegment Revenue
-867.00K-1.03M-2.39M
Revenue (Other)
5.44M--
Revenue (Total)
1.22B1.22B1.16B
Revenue (Total) Growth
-0.33%5.23%1.97%

EBIT

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
Protein Sciences Operating Income
365.03M370.35M354.78M
Protein Sciences Operating Income Growth
-1.44%4.39%-5.06%
Diagnostics and Genomics Operating Income
31.12M21.32M24.55M
Diagnostics and Genomics Operating Income Growth
45.92%-13.13%-42.96%
Operating Income (Total)
116.97M102.26M206.69M
Operating Income (Total) Growth
14.39%-50.53%-30.86%

Key Performance Indicators

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16 Jun '15 Jun '14 Jun '13 Jun '12
Organic Sales Growth
5.00%1.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai.